Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3337478

DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    19.8.2016
  • EP published:
    12.8.2020
  • EP application number:
    16758337.6
  • Max expiry date:
    18.8.2036
  • Title:
    DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER

Timeline

Today
19.8.2016EP application
12.8.2020EP Publication

Owner

  • Name:
    Ipsen Biopharm Ltd.
  • Address:
    Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, GB

Inventor

  • Name:
    BLANCHETTE, Sarah, F.
  • Address:
    Lynnfield, MA 01940, US
  • Name:
    FITZGERALD, Jonathan, Basil
  • Address:
    Arlington, MA 02474, US
  • Name:
    GADDY, Daniel, F.
  • Address:
    Cambridge, MA 02141, US
  • Name:
    HENDRIKS, Bart, S.
  • Address:
    Belmont, MA 02478, US
  • Name:
    KALRA, Ashish
  • Address:
    Belmont, MA 02478, US
  • Name:
    LEE, Helen
  • Address:
    Cambridge, MA 02140, US
  • Name:
    BAYEVER, Eliel
  • Address:
    New York, NY 10023, US

Priority

  • Number:
    201562208209 P
  • Date:
    21.8.2015
  • Country:
    US
  • Number:
    201562216736 P
  • Date:
    10.9.2015
  • Country:
    US
  • Number:
    201562273244 P
  • Date:
    30.12.2015
  • Country:
    US
  • Number:
    201662281473 P
  • Date:
    21.1.2016
  • Country:
    US
  • Number:
    201662302341 P
  • Date:
    2.3.2016
  • Country:
    US
  • Number:
    201662323245 P
  • Date:
    15.4.2016
  • Country:
    US
  • Number:
    201662343313 P
  • Date:
    31.5.2016
  • Country:
    US

Classification

  • Categories:
    A61K 31/436, A61K 9/127, A61K 31/282, A61K 31/4745, A61K 31/475, A61K 31/513, A61K 31/519, A61P 35/04

Upload documents